Showing 121-140 of 176 for: EBMG evidence summaries > Oncology 
- Prevention and treatment of chemotherapy- and radiation-induced oral mucositis
EBMG evidence summaries, 11-Aug-2003
Cryotherapy with ice may be effective for radiation-induced oral mucositis.
- Prevention of oral mucositis in patients receiving treatment for cancer
EBMG evidence summaries, 11-Feb-2008
There are several interventions that are at least of some benefit at preventing or reducing the severity of mucositis associated with cancer treatment, e.g. amifostine, Chinese medicine and hydrolytic enzymes for patients with head and neck cancer, and ic
- Primary groin irradiation vs. primary groin surgery for early vulvar cancer
EBMG evidence summaries, 21-May-2012
Groin surgery may be more effective than groin irradiation in the prevention of groin recurrence in early vulvar cancer.
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
EBMG evidence summaries, 3-May-2012
Primary prophylaxis for venous thromboembolism (VTE) with LMWH appears to reduce the incidence of symptomatic VTE in ambulatory cancer patients receiving chemotherapy. It has no effect on 1-year total mortality but may increase the risk of major bleeding.
- Progestogens and other hormone therapies in women with breast cancer and bone metastasis
EBMG evidence summaries, 11-Aug-2003
Medroxyprogesterone acetate appears to be superior to tamoxifen in breast cancer patients with bone metastasis for global response rates, but there is insufficient evidence of improved survival.
- Prophylactic gastrojejunostomy for unresectable periampullary carcinoma
EBMG evidence summaries, 29-Sep-2011
Routine prophylactic gastrojejunostomy may reduce gastric outlet obstruction in patients with unresectable periampullary cancer undergoing exploratory laparotomy.
- Prophylactic treatments against pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients
EBMG evidence summaries, 11-Aug-2003
Trimethoprim-sulfamethozazole prophylaxis may be more effective than dapsone/pyrimethamine or aerosolised pentamidine in the prophylaxis of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
- PSA for screening of prostate cancer
EBMG evidence summaries, 9-Jan-2013
Screening with PSA testing appears not to decrease total mortality but may decrease prostate cancer-specific mortality at the cost of a high degree of over-diagnosis, treatment and screening related harms
- Psychological interventions for cancer patients
EBMG evidence summaries, 23-Mar-2003
Preventative psychological interventions may have a moderate clinical effect upon anxiety but less upon depression.
- Psychosocial counselling for patients with cancer
EBMG evidence summaries, 20-Mar-2003
Counselling helps patients with cancer in terms of psychosocial adjustments in the months after diagnosis.
- Purine antagonists compared to alkylating agents for chronic lymphocytic leukaemia
EBMG evidence summaries, 9-Jan-2007
First-line treatment of CLL patients with purine antagonists appears to be more effective than alkylator-based therapy in terms of obtaining a complete response and a longer progression-free survival, but purine antagonist use is associated with more seve
- Radical radiotherapy for non-small cell lung cancer in non-operable patients
EBMG evidence summaries, 11-Aug-2003
Radical radiotherapy may result in a better survival that might be expected had treatment not been given.
- Radiotherapy after surgery for early cervical cancer
EBMG evidence summaries, 28-May-2012
Adjuvant radiotherapy after radical surgery may decrease the risk of disease progression compared with no adjuvant radiotherapy in women with stage IB cervical cancer. However, it might not improve overall survival.
- Radiotherapy and surgery in early breast cancer
EBMG evidence summaries, 14-Mar-2006
Radiotherapy plus surgery reduces local recurrence and 15-year breast cancer mortality as compared with surgery alone, but there may be an increase in non-breast-cancer mortality in irradiated women.
- Radiotherapy for early breast cancer
EBMG evidence summaries, 20-Mar-2003
Radiotherapy for breast cancer reduces the risk of recurrence by two thirds. Breast cancer 20-year mortality is decreased by 2–4%, but mortality due to other causes is increased.
- Reducing sexual risk behaviours in adolescents
EBMG evidence summaries, 16-Oct-2006
Both community- and school-based interventions may have the potential to reduce sexual risk behaviours among adolescents.
- Reminder packaging for improving adherence to medications
EBMG evidence summaries, 11-Sep-2006
Reminder packaging may improve adherence to self-administered long-term medications.
- Ribavirin plus interferon versus interferon for chronic hepatitis C
EBMG evidence summaries, 6-May-2010
Ribavirin plus interferon is more effective than interferon alone in clearing hepatitis C virus and improving liver histology in chronic hepatitis C, but the combination therapy significantly increases the risk of several adverse events.
- Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer
EBMG evidence summaries, 9-Apr-2007
The risk of cardiovascular mortality appears to be increased after radiotherapy involving the heart region for childhood cancer, compared with the general population and patients who did not receive radiotherapy.
- Screening for breast cancer with mammography
EBMG evidence summaries, 15-Mar-2010
Screening for breast cancer with mammography slightly reduces breast cancer mortality (absolute risk reduction 0.05%, relative risk reduction 15% to 20%).
